Alpro Pharmacy, Malaysia largest prescription pharmacy chain, and Merck, Sharp & Dohme (Malaysia) Sdn. Bhd. (MSD Malaysia), a subsidiary of Merck & Co., Inc., a global healthcare leader, have joined forces to increase cancer awareness and accessibility of Oncology treatment through a Memorandum of Understanding (MoU).
The initiative focuses on expanding access to oncology medications, raising cancer awareness, and strengthening the availability of oncology treatments. The collaboration will be realised through Alpro ONCOHelp, a dedicated one-stop centre for cancer patients and their family.
Ph. Joelle Wong, Chief Pharmaceutical Officer of Alpro ONCOHelp, said “Our collaboration with MSD Malaysia marks an achievement in our journey to enhance healthcare access and the quality of life for cancer patients through ONCOHelp. This program is a one-of-a-kind initiative designed to provide access to innovative oncology treatments and complimentary 365 days medical holistic support to cancer patient.”
By leveraging its expertise to provide valuable insights into the cancer patient journey, MSD Malaysia can contribute to the development of Alpro Pharmacy initiative, specifically tailored to promote increased access to advanced cancer treatments through the ONCOHelp program. This collaborative effort will broaden the scope of outreach, ensuring a more comprehensive and inclusive approach to patient care.
Dr. Abdullahi Sheriff, MSD Managing Director for Malaysia, Singapore, and Brunei said “MSD Malaysia is dedicated to enhancing the lives of patients by increasing awareness of the challenges posed by cancer and improving access to treatment. We firmly believe that everyone should have access to the medicines and vaccines they require. We are also confident that working with Alpro Pharmacy will yield innovative solutions that will have a positive impact on the lives of numerous cancer patients in Malaysia. ”
Moreover, Alpro Pharmacy and MSD jointly uphold a steadfast dedication to increasing awareness among both medical professionals and the public concerning cancer and the measures that can be implemented for both prevention and treatment. Through this collaborative effort, both organisations are dedicated to working closely towards a shared goal of making a positive and meaningful contribution to the well-being of the Malaysian cancer community, with the aim of enhancing the overall quality of cancer care.
The centralised ONCOHelp team, comprising of health care professionals including doctors, pharmacists, physiotherapists, nutritionists and dietitians, will be providing invaluable patient navigation services, from sourcing affordable cancer medications, assisting in funding for eligible patients, complimentary 365-days medical holistic support for registered patients.